Delivery Order SPE2DX15D3404-SPE2DX23F1BAS
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,674.63, is for the delivery of Celebrex 200 mg capsules to support military healthcare programs. It is a firm-fixed price delivery order contract with a completion date of June 4, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
- This is a federal contract award for the delivery of 4,538,927,482 units of the prescription drug Celebrex (100mg, 100 count) to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $82,164.79 and was awarded on August 10, 2017 to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order with a firm fixed price and has an ultimate completion date of September 7, 2017. The contract is not...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award, valued at $1,124.88, is for the delivery of CELECOXIB 200 MG CAPSULE 500S, a medication used for pain management. The contract is a firm fixed price delivery order with a completion date of December 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
- This federal contract award, valued at $1,050.78, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order contract is for the supply of Celecoxib 200mg medication, a non-set-aside requirement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This federal contract award, valued at $3,558.17, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the delivery of 4,565,938,793 units of Celecoxib 100 mg capsules, a pharmaceutical product, to support various government healthcare programs and federal facilities. This award is not designated as a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, has been...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,597.57 by the Defense Logistics Agency's Medical Supply Chain on July 28, 2025, for the supply of Celebrex 200 mg capsules (100 count). This is a firm fixed-price, non-set-aside competitive contract with performance in Conshohocken, Pennsylvania and an ultimate completion date of July 29, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- This federal contract award, with ID SPE2DB25D3005|SPE2DB25FQEVU, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,434.56 firm fixed-price delivery order is for the supply of 4568142809 Celecoxib 200 mg capsules, and has an ultimate completion date of May 6, 2025. Amerisourcebergen Drug Corp, a for-profit organization based in Conshohocken, Pennsylvania, holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award, SPE2DX15D6028|K387, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $100,229.48 Firm Fixed Price Delivery Order is for 4536241541 - CELEBREX 200MG 100S, a pharmaceutical product. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 500 capsules of Celecoxib 200 mg under a firm fixed-price contract valued at $20,551.98. The award, made on September 24, 2025, represents a non-competitive delivery order with an ultimate completion date of September 25, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office location. This delivery...
- The Defense Logistics Agency awarded a $1,512.46 delivery order to AmerisourceBergen Drug Corp for 500 capsules of Celecoxib 100 mg, a nonsteroidal anti-inflammatory medication. This firm fixed-price contract, with an ultimate completion date of July 1, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The award was competitively awarded without...
- SPE2DX15D3404Indefinite Delivery Contract
- SPE2DX15D3404-SPE2DX23F1BASDelivery Order
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the provision of Celebrex 100 mg capsules to support military healthcare programs. The contract award, valued at $13,128.84, was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency responsible for supplying medical products to the U.S. military. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to the DLA. This IDC enables efficient government procurement of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.1k | 4/18/23 |